Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation

Atul Bedi, Carole B. Miller, Janet L. Hanson, Steven Goodman, Richard F. Ambinder, Patricia Charache, Ray R. Arthur, Richard J. Jones

Research output: Contribution to journalArticle

Abstract

Purpose: Hemorrhagic cystitis (HC) after bone marrow transplantation (BMT) has been ascribed to cyclophosphamide metabolites. HC has also been associated with excretion of the BK type of polyomavirus. The relative contributions of cyclophosphamide metabolites and BK virus in the development of HC following BMT are unknown. Patients and Methods: We conducted a randomized trial to compare mesna with forced diuresis for prophylaxis against HC in 147 BMT recipients. We studied the association of BK virus with HC in 95 consecutive BMT recipients by prospectively monitoring urinary excretion of BK virus using polymerase chain reaction amplification of viral gene sequences. Results: HC occurred in 37 of 147 (25.2%) transplant recipients. The incidence of HC was similar in patients given mesna (26.8%, 19 of 71) or forced diuresis (23.7%, 18 of 76), and in recipients of allogeneic (27.2%, 18 of 64) or autologous marrow (22.9%, 19 of 83). The incidence of HC was unrelated to primary disease, preparative regimen, or occurrence of graft-versus-host disease (GVHD). Excretion of BK virus was demonstrated in 50 of 95 patients (52.6%); 38 patients (40%) had persistent BK viruria (≥ two consecutive positive samples). HC occurred in 19 of 38 patients (50%) with persistent BK viruria, in one of 12 (8.3%) with only a single urine sample positive for BK virus, and in none of 45 who did not excrete BK virus (P <.0001). Shedding of BK virus also had a strong temporal correlation with onset of HC (r = .95). Conclusion: Mesna and forced diuresis are equally effective in abrogating the urothelial toxicity of preparative regimens for BMT. Since HC after BMT is virtually always associated with persistent BK viruria, strategies aimed at the prevention or elimination of viruria in BK seropositive recipients are warranted.

Original languageEnglish (US)
Pages (from-to)1103-1109
Number of pages7
JournalJournal of Clinical Oncology
Volume13
Issue number5
StatePublished - May 1995

Fingerprint

BK Virus
Cystitis
Bone Marrow Transplantation
Mesna
Diuresis
Cyclophosphamide
Viral Genes
Incidence
Graft vs Host Disease

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. / Bedi, Atul; Miller, Carole B.; Hanson, Janet L.; Goodman, Steven; Ambinder, Richard F.; Charache, Patricia; Arthur, Ray R.; Jones, Richard J.

In: Journal of Clinical Oncology, Vol. 13, No. 5, 05.1995, p. 1103-1109.

Research output: Contribution to journalArticle

Bedi, Atul ; Miller, Carole B. ; Hanson, Janet L. ; Goodman, Steven ; Ambinder, Richard F. ; Charache, Patricia ; Arthur, Ray R. ; Jones, Richard J. / Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. In: Journal of Clinical Oncology. 1995 ; Vol. 13, No. 5. pp. 1103-1109.
@article{6ff82b533d5c46a0bd0fa41c539971cb,
title = "Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation",
abstract = "Purpose: Hemorrhagic cystitis (HC) after bone marrow transplantation (BMT) has been ascribed to cyclophosphamide metabolites. HC has also been associated with excretion of the BK type of polyomavirus. The relative contributions of cyclophosphamide metabolites and BK virus in the development of HC following BMT are unknown. Patients and Methods: We conducted a randomized trial to compare mesna with forced diuresis for prophylaxis against HC in 147 BMT recipients. We studied the association of BK virus with HC in 95 consecutive BMT recipients by prospectively monitoring urinary excretion of BK virus using polymerase chain reaction amplification of viral gene sequences. Results: HC occurred in 37 of 147 (25.2{\%}) transplant recipients. The incidence of HC was similar in patients given mesna (26.8{\%}, 19 of 71) or forced diuresis (23.7{\%}, 18 of 76), and in recipients of allogeneic (27.2{\%}, 18 of 64) or autologous marrow (22.9{\%}, 19 of 83). The incidence of HC was unrelated to primary disease, preparative regimen, or occurrence of graft-versus-host disease (GVHD). Excretion of BK virus was demonstrated in 50 of 95 patients (52.6{\%}); 38 patients (40{\%}) had persistent BK viruria (≥ two consecutive positive samples). HC occurred in 19 of 38 patients (50{\%}) with persistent BK viruria, in one of 12 (8.3{\%}) with only a single urine sample positive for BK virus, and in none of 45 who did not excrete BK virus (P <.0001). Shedding of BK virus also had a strong temporal correlation with onset of HC (r = .95). Conclusion: Mesna and forced diuresis are equally effective in abrogating the urothelial toxicity of preparative regimens for BMT. Since HC after BMT is virtually always associated with persistent BK viruria, strategies aimed at the prevention or elimination of viruria in BK seropositive recipients are warranted.",
author = "Atul Bedi and Miller, {Carole B.} and Hanson, {Janet L.} and Steven Goodman and Ambinder, {Richard F.} and Patricia Charache and Arthur, {Ray R.} and Jones, {Richard J.}",
year = "1995",
month = "5",
language = "English (US)",
volume = "13",
pages = "1103--1109",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "5",

}

TY - JOUR

T1 - Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation

AU - Bedi, Atul

AU - Miller, Carole B.

AU - Hanson, Janet L.

AU - Goodman, Steven

AU - Ambinder, Richard F.

AU - Charache, Patricia

AU - Arthur, Ray R.

AU - Jones, Richard J.

PY - 1995/5

Y1 - 1995/5

N2 - Purpose: Hemorrhagic cystitis (HC) after bone marrow transplantation (BMT) has been ascribed to cyclophosphamide metabolites. HC has also been associated with excretion of the BK type of polyomavirus. The relative contributions of cyclophosphamide metabolites and BK virus in the development of HC following BMT are unknown. Patients and Methods: We conducted a randomized trial to compare mesna with forced diuresis for prophylaxis against HC in 147 BMT recipients. We studied the association of BK virus with HC in 95 consecutive BMT recipients by prospectively monitoring urinary excretion of BK virus using polymerase chain reaction amplification of viral gene sequences. Results: HC occurred in 37 of 147 (25.2%) transplant recipients. The incidence of HC was similar in patients given mesna (26.8%, 19 of 71) or forced diuresis (23.7%, 18 of 76), and in recipients of allogeneic (27.2%, 18 of 64) or autologous marrow (22.9%, 19 of 83). The incidence of HC was unrelated to primary disease, preparative regimen, or occurrence of graft-versus-host disease (GVHD). Excretion of BK virus was demonstrated in 50 of 95 patients (52.6%); 38 patients (40%) had persistent BK viruria (≥ two consecutive positive samples). HC occurred in 19 of 38 patients (50%) with persistent BK viruria, in one of 12 (8.3%) with only a single urine sample positive for BK virus, and in none of 45 who did not excrete BK virus (P <.0001). Shedding of BK virus also had a strong temporal correlation with onset of HC (r = .95). Conclusion: Mesna and forced diuresis are equally effective in abrogating the urothelial toxicity of preparative regimens for BMT. Since HC after BMT is virtually always associated with persistent BK viruria, strategies aimed at the prevention or elimination of viruria in BK seropositive recipients are warranted.

AB - Purpose: Hemorrhagic cystitis (HC) after bone marrow transplantation (BMT) has been ascribed to cyclophosphamide metabolites. HC has also been associated with excretion of the BK type of polyomavirus. The relative contributions of cyclophosphamide metabolites and BK virus in the development of HC following BMT are unknown. Patients and Methods: We conducted a randomized trial to compare mesna with forced diuresis for prophylaxis against HC in 147 BMT recipients. We studied the association of BK virus with HC in 95 consecutive BMT recipients by prospectively monitoring urinary excretion of BK virus using polymerase chain reaction amplification of viral gene sequences. Results: HC occurred in 37 of 147 (25.2%) transplant recipients. The incidence of HC was similar in patients given mesna (26.8%, 19 of 71) or forced diuresis (23.7%, 18 of 76), and in recipients of allogeneic (27.2%, 18 of 64) or autologous marrow (22.9%, 19 of 83). The incidence of HC was unrelated to primary disease, preparative regimen, or occurrence of graft-versus-host disease (GVHD). Excretion of BK virus was demonstrated in 50 of 95 patients (52.6%); 38 patients (40%) had persistent BK viruria (≥ two consecutive positive samples). HC occurred in 19 of 38 patients (50%) with persistent BK viruria, in one of 12 (8.3%) with only a single urine sample positive for BK virus, and in none of 45 who did not excrete BK virus (P <.0001). Shedding of BK virus also had a strong temporal correlation with onset of HC (r = .95). Conclusion: Mesna and forced diuresis are equally effective in abrogating the urothelial toxicity of preparative regimens for BMT. Since HC after BMT is virtually always associated with persistent BK viruria, strategies aimed at the prevention or elimination of viruria in BK seropositive recipients are warranted.

UR - http://www.scopus.com/inward/record.url?scp=0029052047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029052047&partnerID=8YFLogxK

M3 - Article

C2 - 7738616

AN - SCOPUS:0029052047

VL - 13

SP - 1103

EP - 1109

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 5

ER -